Repositorio Institucional de la Universidad de Oviedo

Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: Results of the PRO-R-IPI study

Author:

Panizo, C.; Jaramillo, A.; Gutiérrez, Gonzalo; González Rodríguez, Ana Pilar

Publication date:

2015

Publisher version:

http://dx.doi.org/10.1016/j.clml.2015.02.029

Citación:

Clinical Lymphoma, Myeloma and Leukemia, 15(7), p. 398-403 (2015); doi:10.1016/j.clml.2015.02.029

Descripción física:

p. 398-403

URI:

http://hdl.handle.net/10651/34198

ISSN:

2152-2650

DOI:

10.1016/j.clml.2015.02.029